Systemic Capecitabine and Oxaliplatin Administered with Hepatic Arterial Infusion (HAI) of Floxuridine (FUDR) Following Resection of Colorectal Metastases (M-CRC) Confined…

National Liver EQA Scheme Circulation U Glasgow March 27th 2007 Business meeting Increasing membership â increase number of cells, 6 per cell Second class post â increase…

Aging, Frailty, and Medical Therapy for Colorectal Cancer: Who Should Be Treated and How? Aging, Frailty, and Medical Therapy for Colorectal Cancer: Who Should Be Treated…

LIVER SURGERY http://liversurgeryny.com/ ABOUT LIVER SURGERY Liver surgery comprises various operations of the liver for different disorders. The most common operation performed…

Slide 1 Management of Recurrent and Advanced Tumours: When are Tumours Resectable, and Multidisciplinary Management Dr. Andrew McFadden Surgical Oncology Management of Recurrent…

Info: Surgical Approach To Liver Metastases from Colorectal Cancer 1 The topics of this lecture: The latest changes in surgery of liver metastatic colorectal cancer. Preoperative…

Management of Hepatocellular Adenoma: Recent AdvancesShefali Agrawal,* Sheela Agarwal,‡ Thomas Arnason,§ Sanjay Saini,‡ and Jacques Belghitik *Hepatobiliary

UntitledTwo pseudotumor cases mimicking liver malignancy Inflammatory pseudotumor of the liver is a rare benign tumor that can be confused with malignant tumors of the liver.

untitled368 Abstract. – Hilar cholangiocarcinoma (HC) is a rare tumor which has to be distinguished by intrahepatic cholagiocarcinoma invading hepatic hilum because

Intrahepatic CholangiocarcinomaIntrahepatic Cholangiocarcinoma George A. Poultsides, MDa, Andrew X. Zhu, MDb,c, Michael A. Choti, MD, MBAd, Timothy M. Pawlik, MD, MPHe,*